Fetal Hydantoin Syndrome in Triplets
- 1 October 1978
- journal article
- research article
- Published by American Medical Association (AMA) in American Journal of Diseases of Children
- Vol. 132 (10) , 978-979
- https://doi.org/10.1001/archpedi.1978.02120350042006
Abstract
• Birth defects associated with phenytoin and phenobarbital taken during pregnancy include craniofacial and limb deformities. These anomalies were found in various degrees of severity in triplets born to a mother taking phenobarbital and phenytoin for an epileptic disorder, giving us a unique opportunity to recognize different manifestations of the hydantoin syndrome in infants that presumably were exposed to the same level of the drugs. These infants were trizygotic and their clinical manifestations varied widely, suggesting the possibility that genetic background may play a significant role in the susceptibility of the fetus to phenytoin and phenobarbital during pregnancy. (Am J Dis Child 132:978-979, 1978)This publication has 10 references indexed in Scilit:
- Teratogenicity of Anticonvulsive MedicationsArchives of Pediatrics & Adolescent Medicine, 1977
- Abnormal Genitalia as a Presenting Sign in Two Male Infants With Hydantoin Embryopathy SyndromeArchives of Pediatrics & Adolescent Medicine, 1977
- Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndromeThe Journal of Pediatrics, 1976
- Fetal Malformations and Antiepileptic DrugsArchives of Pediatrics & Adolescent Medicine, 1976
- Teratogenic Effect of Anticonvulsant DrugsArchives of Pediatrics & Adolescent Medicine, 1976
- Congenital Malformations in Four Siblings of a Mother Taking Anticonvulsant DrugsArchives of Pediatrics & Adolescent Medicine, 1976
- The fetal hydantoin syndromeThe Journal of Pediatrics, 1975
- The Teratogenic Risk of Antiepileptic DrugsEpilepsia, 1975
- Epilepsy and Pregnancy: A Report from the Oxford Record Linkage StudyBMJ, 1973
- The Denver Developmental Screening TestPublished by Elsevier ,1967